Invesco’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-422
| Closed | -$159K | – | 3862 |
|
|
2020
Q4 | $159K | Buy |
422
+40
| +10% | +$15.1K | ﹤0.01% | 3543 |
|
|
2020
Q3 | $117K | Sell |
382
-11
| -3% | -$3.37K | ﹤0.01% | 3523 |
|
|
2020
Q2 | $148K | Sell |
393
-23,490
| -98% | -$8.85M | ﹤0.01% | 3501 |
|
|
2020
Q1 | $5.44M | Sell |
23,883
-23,844
| -50% | -$5.44M | ﹤0.01% | 1827 |
|
|
2019
Q4 | $25.2M | Buy |
47,727
+109
| +0.2% | +$57.7K | 0.01% | 1290 |
|
|
2019
Q3 | $20.5M | Sell |
47,618
-47
| -0.1% | -$20.3K | 0.01% | 1394 |
|
|
2019
Q2 | $56.8M | Buy |
+47,665
| New | +$56.8M | 0.01% | 975 |
|
|
2018
Q2 | – | Sell |
-1,178
| Closed | -$1.91M | – | 3853 |
|
|
2018
Q1 | $1.91M | Sell |
1,178
-617
| -34% | -$1M | ﹤0.01% | 2621 |
|
|
2017
Q4 | $3.01M | Buy |
+1,795
| New | +$3.01M | ﹤0.01% | 2296 |
|
|
2016
Q4 | – | Sell |
-1,294
| Closed | -$925K | – | 3662 |
|
|
2016
Q3 | $925K | Buy |
1,294
+118
| +10% | +$84.4K | ﹤0.01% | 2989 |
|
|
2016
Q2 | $855K | Buy |
+1,176
| New | +$855K | ﹤0.01% | 2987 |
|